• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用1998年世界卫生组织/国际泌尿病理学会尿路上皮肿瘤分类法时观察者间的差异:患者护理的实际选择

Interobserver discrepancy using the 1998 World Health Organization/International Society of Urologic Pathology classification of urothelial neoplasms: practical choices for patient care.

作者信息

Murphy William M, Takezawa Kimiko, Maruniak Nicholas A

机构信息

Department of Pathology, University of Florida College of Medicine, Gainsville, Florida, USA.

出版信息

J Urol. 2002 Sep;168(3):968-72. doi: 10.1016/S0022-5347(05)64553-3.

DOI:10.1016/S0022-5347(05)64553-3
PMID:12187201
Abstract

PURPOSE

Morphological classifications designed by experts to stratify neoplasms according to biological potential must define categories that are reproducible among practitioners or the schemes actually create the heterogeneous populations that they seek to avoid. The application of the 1998 World Health Organization/International Society of Urologic Pathology scheme for urothelial neoplasms was studied in a community practice setting. We documented interpretive discrepancies for each category of neoplasm and determined whether a period of pathologist education may have a positive effect on the frequency of discrepant interpretations. The results suggest that patients may benefit from modifying the classification system.

MATERIALS AND METHODS

A consecutive series of specimens was divided into learning and study sets that were each independently examined by 3 pathologists. Specimens in the learning set were interpreted without previous structured education, while those in the study set were interpreted immediately after intensive education. Interpretations for each specimen were compared and interpretive discrepancies were analyzed.

RESULTS

Case distribution after education was similar among the pathologists but interpretations for any particular specimen often differed. The level of interpretive discrepancies varied according to the morphological similarity among categories in the classification scheme and was not necessarily decreased by education. When pathologists were required to discriminate between papillary urothelial neoplasm of low malignant potential and low grade carcinoma, the discrepancies were 50% after education compared with 39% before education. In contrast, there were no discrepancies when the discrimination was between papillary urothelial neoplasm of low malignant potential and high grade carcinoma or carcinoma in situ. Eliminating categories with poor reproducibility markedly improved the likelihood of unanimous agreement among practitioners but a probably irreducible level of 10% discrepancies remained.

CONCLUSIONS

The 1998 World Health Organization/International Society of Urologic Pathology classification of urothelial neoplasms requires certain discriminations that cannot be reliably made by practitioners. Modifying the scheme to create categories of low grade neoplasm and high grade carcinoma would markedly increase its practical value to patients without significantly altering patient care.

摘要

目的

由专家设计的根据生物学潜能对肿瘤进行分层的形态学分类,必须定义出在从业者之间可重复的类别,否则该方案实际上会产生它试图避免的异质性群体。我们在社区实践环境中研究了1998年世界卫生组织/国际泌尿病理学会的尿路上皮肿瘤分类方案的应用。我们记录了每种肿瘤类别的解释差异,并确定病理学家的教育阶段是否可能对差异解释的频率产生积极影响。结果表明,修改分类系统可能会使患者受益。

材料与方法

将一系列连续的标本分为学习组和研究组,每组由3名病理学家独立检查。学习组的标本在没有先前结构化教育的情况下进行解释,而研究组的标本在强化教育后立即进行解释。比较每个标本的解释并分析解释差异。

结果

教育后病理学家之间的病例分布相似,但对任何特定标本的解释往往不同。解释差异的程度根据分类方案中类别之间的形态学相似性而有所不同,并且不一定因教育而降低。当要求病理学家区分低恶性潜能的乳头状尿路上皮肿瘤和低级别癌时,教育后的差异为50%,而教育前为39%。相比之下,当区分低恶性潜能的乳头状尿路上皮肿瘤与高级别癌或原位癌时,没有差异。消除可重复性差的类别显著提高了从业者之间达成一致意见的可能性,但仍有10%的差异可能无法消除。

结论

1998年世界卫生组织/国际泌尿病理学会的尿路上皮肿瘤分类需要进行某些从业者无法可靠做出的区分。修改该方案以创建低级别肿瘤和高级别癌的类别,将显著增加其对患者的实用价值,而不会显著改变患者护理。

相似文献

1
Interobserver discrepancy using the 1998 World Health Organization/International Society of Urologic Pathology classification of urothelial neoplasms: practical choices for patient care.采用1998年世界卫生组织/国际泌尿病理学会尿路上皮肿瘤分类法时观察者间的差异:患者护理的实际选择
J Urol. 2002 Sep;168(3):968-72. doi: 10.1016/S0022-5347(05)64553-3.
2
Comparison of the WHO/ISUP classification and cytokeratin 20 expression in predicting the behavior of low-grade papillary urothelial tumors. World/Health Organization/Internattional Society of Urologic Pathology.世界卫生组织/国际泌尿病理学会分类与细胞角蛋白20表达在预测低级别乳头状尿路上皮肿瘤行为中的比较
Mod Pathol. 2001 Apr;14(4):267-72. doi: 10.1038/modpathol.3880300.
3
Histologic grading of urothelial carcinoma: a reappraisal.尿路上皮癌的组织学分级:再评价。
Hum Pathol. 2012 Dec;43(12):2097-108. doi: 10.1016/j.humpath.2012.01.008. Epub 2012 Apr 26.
4
The effects of the current World Health Organization/International Society of Urologic Pathologists bladder neoplasm classification system on urine cytology results.当前世界卫生组织/国际泌尿病理学家学会膀胱肿瘤分类系统对尿液细胞学检查结果的影响。
Cancer. 2002 Jun 25;96(3):140-5. doi: 10.1002/cncr.10621.
5
Reproducibility of the 1998 World Health Organization/International Society of Urologic Pathology classification of papillary urothelial neoplasms of the urinary bladder.1998年世界卫生组织/国际泌尿病理学会膀胱乳头状尿路上皮肿瘤分类的可重复性
Virchows Arch. 2003 Dec;443(6):734-40. doi: 10.1007/s00428-003-0905-0. Epub 2003 Oct 8.
6
Urothelial neoplasia of the urinary bladder--comparison of interobserver variability for WHO Classification 1972 with WHO/ISUP Consensus Classification 1998.膀胱尿路上皮肿瘤——1972年世界卫生组织分类与1998年世界卫生组织/国际泌尿病理学会共识分类的观察者间变异性比较
J Ayub Med Coll Abbottabad. 2006 Apr-Jun;18(2):4-8.
7
How to Name Papillary Tumors of the Bladder in Children: Transitional Cell Carcinoma or Papillary Urothelial Neoplasm of Low Malignant Potential?如何命名儿童膀胱乳头状肿瘤:移行细胞癌还是低恶性潜能乳头状尿路上皮肿瘤?
Urology. 2015 Aug;86(2):379-83. doi: 10.1016/j.urology.2015.04.021. Epub 2015 Jul 10.
8
Urothelial neoplasms in patients 20 years or younger: a clinicopathological analysis using the world health organization 2004 bladder consensus classification.20岁及以下患者的尿路上皮肿瘤:一项使用世界卫生组织2004年膀胱共识分类的临床病理分析
J Urol. 2005 Nov;174(5):1976-80. doi: 10.1097/01.ju.0000176801.16827.82.
9
The 2004 WHO classification of bladder tumors: a summary and commentary.2004年世界卫生组织膀胱肿瘤分类:总结与评论
Int J Surg Pathol. 2005 Apr;13(2):143-53. doi: 10.1177/106689690501300203.
10
Validation of World Health Organization/International Society of Urologic Pathology 2004 classification schema for bladder urothelial carcinomas using quantitative nuclear morphometry: identification of predictive features using bootstrap method.使用定量核形态计量学验证世界卫生组织/国际泌尿病理学会2004年膀胱尿路上皮癌分类方案:采用自助法识别预测特征
Urology. 2007 Nov;70(5):1028-33. doi: 10.1016/j.urology.2007.09.003.

引用本文的文献

1
Anti-Metastatic Effect of Pyruvate Dehydrogenase Kinase 4 Inhibition in Bladder Cancer via the ERK, SRC, and JNK Pathways.丙酮酸脱氢酶激酶 4 抑制通过 ERK、SRC 和 JNK 通路在膀胱癌中的抗转移作用。
Int J Mol Sci. 2022 Oct 31;23(21):13240. doi: 10.3390/ijms232113240.
2
Bladder cancer prognosis using deep neural networks and histopathology images.使用深度神经网络和组织病理学图像预测膀胱癌预后
J Pathol Inform. 2022 Aug 28;13:100135. doi: 10.1016/j.jpi.2022.100135. eCollection 2022.
3
Assessment of Histopathological Parameters Useful in the Diagnosis of Low Grade Non-Invasive Urothelial Carcinomas.
评估对低级别非浸润性尿路上皮癌诊断有用的组织病理学参数。
Curr Health Sci J. 2019 Oct-Dec;45(4):383-389. doi: 10.12865/CHSJ.45.04.06. Epub 2019 Dec 30.
4
Are we closer to seeing carcinoma in situ in the upper urinary tract?我们距离在上尿路中发现原位癌更近了吗?
Cent European J Urol. 2016;69(2):157-61. doi: 10.5173/ceju.2016.801. Epub 2016 Apr 26.
5
Role of morphometry and proliferative parameters in grading of urothelial neoplasms.形态测量学和增殖参数在上皮性肿瘤分级中的作用。
Cent European J Urol. 2015;68(1):37-44. doi: 10.5173/ceju.2015.01.447. Epub 2015 Mar 13.
6
Long-term outcome of primary Papillary Urothelial Neoplasm of Low Malignant Potential (PUNLMP) including PUNLMP with inverted growth.原发性低恶性潜能乳头状尿路上皮肿瘤(PUNLMP)的长期预后,包括具有内翻性生长的PUNLMP。
Diagn Pathol. 2015 Mar 13;10:3. doi: 10.1186/s13000-015-0234-z.
7
Urotensin II receptor determines prognosis of bladder cancer regulating cell motility/invasion.尾加压素II受体通过调节细胞运动/侵袭来决定膀胱癌的预后。
J Exp Clin Cancer Res. 2014 Jun 3;33(1):48. doi: 10.1186/1756-9966-33-48.
8
Reproducibility and prognostic value of WHO1973 and WHO2004 grading systems in TaT1 urothelial carcinoma of the urinary bladder.WHO1973 和 WHO2004 分级系统在膀胱 TaT1 尿路上皮癌中的可重复性和预后价值。
PLoS One. 2014 Jan 7;9(1):e83192. doi: 10.1371/journal.pone.0083192. eCollection 2014.
9
Impact of concomitant carcinoma in situ on upstaging and outcome following radical cystectomy for bladder cancer.原位癌并存对膀胱癌根治性膀胱切除术后分期上调及预后的影响。
World J Urol. 2014 Oct;32(5):1295-301. doi: 10.1007/s00345-013-1207-z. Epub 2013 Nov 10.
10
Three-gene signature predicts disease progression of non-muscle invasive bladder cancer.三基因特征可预测非肌层浸润性膀胱癌的疾病进展。
Oncol Lett. 2011 Jul;2(4):679-684. doi: 10.3892/ol.2011.309. Epub 2011 May 13.